NuCana Plc (NCNA)
3.60
+0.07
(+1.98%)
USD |
NASDAQ |
Dec 31, 16:00
3.63
+0.03
(+0.83%)
After-Hours: 20:00
NuCana Cash from Investing (Quarterly): -0.0656M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Autolus Therapeutics Plc | 35.49M |
| Mereo BioPharma Group Plc | 0.3027M |
| Bicycle Therapeutics Plc | -0.6709M |
| Adaptimmune Therapeutics Plc | 18.84M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.586M |
| Cash from Financing (Quarterly) | 20.55M |
| Free Cash Flow | -18.19M |
| Free Cash Flow Per Share (Quarterly) | 0.4112 |
| Free Cash Flow to Equity (Quarterly) | 1.548M |
| Free Cash Flow to Firm (Quarterly) | 1.520M |
| Free Cash Flow Yield | -422.0% |